SCHEMBL6352170

SCHEMBL6352170

COc1cc(Br)c(C(=O)Nc2ccc(Br)cc2C(=O)O)cc1OC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 1/20 0.59
FYN P06241 1/20 0.59
MAPT P10636 4/20 0.54
LMNA P02545 2/20 0.54
ALDH1A1 P00352 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
KDM4E B2RXH2 2/20 0.54
HPGD P15428 1/20 0.54
POLB P06746 4/20 0.53
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
AKR1C2 P52895 3/20 0.52
AKR1C1 Q04828 3/20 0.52
AKR1C4 P17516 2/20 0.52
AKR1C3 P42330 2/20 0.52
GFER P55789 1/20 0.52
HSD17B10 Q99714 1/20 0.52
GAA P10253 1/20 0.52
RECQL P46063 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6352804 0.83 AKR1C2 (0.58) MAPTLMNAALDH1A1SMN1; SMN2KDM4E
SCHEMBL6359832 0.83 MAPT (0.57) MAPTLMNAHPGDPOLBNPC1
SCHEMBL6349632 0.83 CHEK1 (0.70) MAPTLMNAALDH1A1SMN1; SMN2KDM4E
SCHEMBL1306361 0.82 AKR1C2 (0.59) MAPTLMNASMN1; SMN2KDM4EPOLB
SCHEMBL6349404 0.81 LMNA (0.81) LMNAALDH1A1SMN1; SMN2HPGDPOLB
SCHEMBL6353191 0.79 LMNA (0.60) MAPTLMNAALDH1A1SMN1; SMN2KDM4E
SCHEMBL15702354 0.78 ABL1 (0.79) LMNAALDH1A1SMN1; SMN2KDM4EPOLB
SCHEMBL6360748 0.78 AKR1C2 (0.60) MAPTLMNAALDH1A1SMN1; SMN2POLB
SCHEMBL6349859 0.77 MAPT (0.76) MAPTLMNAALDH1A1SMN1; SMN2KDM4E
SCHEMBL6349807 0.77 AKR1C2 (0.63) MAPTLMNAALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed
WO-2004018414-A2 ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 LCK 3115/4885FYN 4411/4885MAPT 4753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.